Morgan Stanley Downgrades Mural Oncology (NASDAQ:MURA) to Equal Weight
Mural Oncology (NASDAQ:MURA – Get Free Report) was downgraded by stock analysts at Morgan Stanley from an “overweight” rating to an “equal weight” rating in a report released on Tuesday, Marketbeat.com reports. A number of other analysts have also weighed in on the stock. HC Wainwright restated a “buy” rating and set a $18.00 target […]
Mural Oncology (NASDAQ:MURA – Get Free Report) was downgraded by stock analysts at Morgan Stanley from an “overweight” rating to an “equal weight” rating in a report released on Tuesday, Marketbeat.com reports. A number of other analysts have also weighed in on the stock. HC Wainwright restated a “buy” rating and set a $18.00 target […]
